Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Warfarin found to increase adverse outcomes among transplant patients IPF

Publish date:: May 31, 2019

Key clinical point: Patients with interstitial lung disease who need anticoagulation therapy may have poorer long-term outcomes on warfarin than with oral anticoagulants.

Major finding: Compared with oral therapy, warfarin doubled the risk of lung transplant or death.

Study details: The retrospective cohort study comprised 1,918 patients.

Disclosures: Dr. King had no disclosures.

Citation:

REPORTING FROM ATS 2019

This Week's Must Reads

Osteoporosis prevalence in PsA similar to general population,

Swedish registry study finds atopic dermatitis significantly associated with autoimmune diseases,

Weight loss may be paramount lifestyle change in preventing gout,

Gut microbiome influences response to methotrexate in new-onset RA patients,

Early treatment of RA with DMARDs promotes sustained remission,

Must Reads in Lupus & Connective Tissue Diseases

High-need, high-cost lupus patients described for first time,

Slow taper off antimalarial is best to avoid lupus flare during remission,

Sjögren’s symptom clusters may identify treatment options,

Transcutaneous VNS on the ear shows positive effects in lupus pilot trial,

ASSET extension supports abatacept as treatment for diffuse cutaneous systemic sclerosis,